ClinicalTrials.gg
Sign In

Hemorrhagic Stroke clinical trials

The registry lists 233 studies for Hemorrhagic Stroke across more than 10 countries. 93 are recruiting or about to start. 53 of them are mainly about Hemorrhagic Stroke (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Hemorrhagic Stroke studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
96
Recruiting
62
Not yet recruiting
29
Status unknown
20
Terminated
10
Active, not recruiting
9

Phase

Phase 2
15
Phase 4
13
Phase 3
12
Phase 1
8
Early Phase 1
3

Where

United States
76
China
25
Italy
17
Germany
14
Canada
13
Spain
12

Who runs them

University Hospital Heidelberg (5) · University of Minnesota (4) · University Hospital, Basel, Switzerland (4) · University of British Columbia (4) · University of Rochester (3) · State University of New York at Buffalo (3) · Fondazione Don Carlo Gnocchi Onlus (3) · Beijing Tiantan Hospital (3)

What is being tested here

Drugs under test in Hemorrhagic Stroke studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Minocycline123
Tenecteplase112
Tranexamic Acid112
Methylprednisolone101
Melatonin101
Cerebrolysin101
Amantadine101
Atorvastatin101
Psilocybin101
Edoxaban001

Drug classes tested here Beta blockers 3

Coming up

1phase 3 study under way
34studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 62 Hemorrhagic Stroke studies recruiting now, 36 (58%) set no upper age limit and 7 (11%) stop at 75 or younger. 5 (8%) take children under 18. 1 (2%) are for women only and 0 (0%) for men only; 7 (11%) take healthy volunteers.

Recruiting studies that take each age, of 62
AgeWomenMen
103 (5%)3 (5%)
1854 (87%)53 (85%)
3060 (97%)59 (95%)
4062 (100%)61 (98%)
5061 (98%)60 (97%)
6560 (97%)59 (95%)
7558 (94%)57 (92%)
8545 (73%)44 (71%)

Across all 233 studies, recruiting or not: 11% stop at 75 or younger and 4% at 65; 7% take children; 1% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hemorrhagic Stroke studies take

Of 89 interventional studies with no phase under Hemorrhagic Stroke, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase36 mo14–56 · 89 studies—38 mo14–57 · 75 studies
Observational86 mo20–… · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 233. Browse all 233 → or search them.